Fig. 4. Protein expression of VEGF, phosphorylated protein kinase B (p-PKB), and phosphorylated mammalian target of rapamycin (p-mTOR) in the angiogenic sites. (A) Western blot analysis of VEGF, p-PKB, and p-mTOR following 1,2-DCP treatment in mice. Actin was used as a loading control. (B, C) Graph shows densitometric quantification of bands. The results are means ± SD of two independent experiments. *p < 0.05; **p<0.01.
© ToxicolRes
